DK355485A - Dinatrium-3-amino-l-hydroxy-propan-1,1-diphosphonat samt fremgangsmaade til fremstilling deraf - Google Patents

Dinatrium-3-amino-l-hydroxy-propan-1,1-diphosphonat samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK355485A
DK355485A DK355485A DK355485A DK355485A DK 355485 A DK355485 A DK 355485A DK 355485 A DK355485 A DK 355485A DK 355485 A DK355485 A DK 355485A DK 355485 A DK355485 A DK 355485A
Authority
DK
Denmark
Prior art keywords
dinate
diphosphonate
propan
hydroxy
procedures
Prior art date
Application number
DK355485A
Other languages
English (en)
Other versions
DK355485D0 (da
DK167282B1 (da
Inventor
Peter Heinrich Stahl
Beat Schmitz
Original Assignee
Ciba Geigy Ag
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4263070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK355485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag, Henkel Kgaa filed Critical Ciba Geigy Ag
Publication of DK355485D0 publication Critical patent/DK355485D0/da
Publication of DK355485A publication Critical patent/DK355485A/da
Application granted granted Critical
Publication of DK167282B1 publication Critical patent/DK167282B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK355485A 1984-08-06 1985-08-05 Krystallinsk, krystalvandholdigt dinatrium-3-amino-1-hydroxy-propan-1,1-diphosphonat paa ikke-hygroskopisk form, fremgangsmaader til fremstilling deraf, anvendelse deraf til fremstilling af farmaceutiske praeparater samt farmaceutiske praeparater med indhold deraf DK167282B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH376884 1984-08-06
CH376884 1984-08-06

Publications (3)

Publication Number Publication Date
DK355485D0 DK355485D0 (da) 1985-08-05
DK355485A true DK355485A (da) 1986-02-07
DK167282B1 DK167282B1 (da) 1993-10-04

Family

ID=4263070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK355485A DK167282B1 (da) 1984-08-06 1985-08-05 Krystallinsk, krystalvandholdigt dinatrium-3-amino-1-hydroxy-propan-1,1-diphosphonat paa ikke-hygroskopisk form, fremgangsmaader til fremstilling deraf, anvendelse deraf til fremstilling af farmaceutiske praeparater samt farmaceutiske praeparater med indhold deraf

Country Status (26)

Country Link
US (2) US4639338A (da)
EP (1) EP0177443B1 (da)
JP (1) JPS6143196A (da)
KR (1) KR940000817B1 (da)
AR (4) AR240832A1 (da)
AT (1) ATE47396T1 (da)
AU (1) AU591066B2 (da)
CA (1) CA1255694A (da)
CY (1) CY1570A (da)
DD (1) DD239597A5 (da)
DE (1) DE3573783D1 (da)
DK (1) DK167282B1 (da)
DO (1) DOP1990004769A (da)
ES (2) ES8701188A1 (da)
FI (1) FI79712C (da)
GR (1) GR851910B (da)
HK (1) HK42591A (da)
HU (1) HU193124B (da)
IE (1) IE58077B1 (da)
IL (1) IL75990A (da)
MX (1) MX9203373A (da)
NO (1) NO165401C (da)
PH (1) PH24854A (da)
PT (1) PT80916B (da)
SG (1) SG91390G (da)
ZA (1) ZA855892B (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
TW237386B (da) 1992-04-15 1995-01-01 Ciba Geigy
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
JP3266395B2 (ja) * 1993-11-24 2002-03-18 富士写真フイルム株式会社 有機薬品の晶析方法
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PT891979E (pt) * 1997-07-15 2005-02-28 Gador Sa Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao
EP1702924A3 (en) * 1998-08-27 2007-07-18 Teva Pharmaceutical Industries Ltd Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
AU5698899A (en) * 1998-08-27 2000-03-21 Teva Pharmaceutical Industries Ltd. Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US6160165A (en) * 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
DE69907258T2 (de) * 1998-12-10 2003-11-06 Aesgen Inc Verfahren zur herstellung von dinatriumpamidronat
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
KR100343232B1 (ko) * 1999-12-10 2002-07-10 김재윤 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법
KR20030043931A (ko) * 2000-09-18 2003-06-02 에프. 에이취. 펄딩 앤드 컴파니 리미티드 디포스포네이트 용액
WO2002058708A1 (en) * 2001-01-23 2002-08-01 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
SK13522003A3 (sk) 2001-05-02 2004-04-06 Sicor Inc. Injikovateľný pamidronát disodný a spôsob jeho prípravy
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP1465606A4 (en) * 2001-12-24 2009-04-22 Teva Pharma DOSAGE FORM WITH PASTILLE CORE ACTIVE PRINCIPLE COATED IN COMPRESSED ANNULAR BODY OF POWDER OR GRANULAR SUBSTANCE, AND METHOD AND TOOLS FOR PRODUCTION OF SAID DOSAGE FORM
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
PT1790347E (pt) * 2002-12-20 2015-02-05 Hoffmann La Roche Formulação de ibandronato a dose elevada
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
AU2003286309A1 (en) * 2003-12-04 2005-06-24 Mustafa Nevzat Ilac Sanayii A.S. Method for producing pure disodium pamidronate
CN1956706A (zh) 2004-05-24 2007-05-02 宝洁公司 包含一种螯合剂的双膦酸酯肠溶固体口服剂型
EP1802641B8 (en) * 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
WO2007109585A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
WO2008116133A1 (en) * 2007-03-21 2008-09-25 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
EP2473172B1 (en) 2009-09-01 2015-04-08 Duke University Bisphosphonate compositions and methods for treating heart failure
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
RU2012148716A (ru) 2010-04-16 2014-05-27 Новартис Аг Способы и композиции для улучшения оссеоинтеграции имплантата
WO2013074587A1 (en) 2011-11-16 2013-05-23 Duke University Bishophonate compositions and methods for treating and/or reducing cardiac dysfunction
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
ES2667535T3 (es) * 2012-05-14 2018-05-11 Antecip Bioventures Ii Llc Composiciones que comprenden ácido zoledrónico o compuestos relacionados para aliviar el dolor inflamatorio y afecciones relacionadas
KR101995432B1 (ko) * 2016-10-13 2019-07-02 엘지전자 주식회사 공기조화기 및 그 제어방법
EP3553067A1 (en) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph of sodium neridronate and preparation process thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
JPS5283957A (en) * 1975-12-01 1977-07-13 Henkel & Cie Gmbh Medicine for treating metabolic obstruction of calcium
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
DE2702631A1 (de) * 1977-01-22 1978-07-27 Henkel Kgaa Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren
DE2943498C2 (de) * 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) * 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
ES545899A0 (es) 1986-11-16
SG91390G (en) 1991-01-18
KR940000817B1 (ko) 1994-02-02
ES8706707A1 (es) 1987-07-01
DE3573783D1 (en) 1989-11-23
PH24854A (en) 1990-12-26
ATE47396T1 (de) 1989-11-15
NO165401C (no) 1991-02-06
DK355485D0 (da) 1985-08-05
JPS6143196A (ja) 1986-03-01
HUT38361A (en) 1986-05-28
JPH058717B2 (da) 1993-02-02
ES8701188A1 (es) 1986-11-16
ES555602A0 (es) 1987-07-01
AU4577785A (en) 1986-02-13
EP0177443A1 (de) 1986-04-09
FI852986L (fi) 1986-02-07
GR851910B (da) 1985-12-03
PT80916B (pt) 1987-12-30
AR240832A2 (es) 1991-02-28
US4711880A (en) 1987-12-08
PT80916A (en) 1985-09-01
AR244697A1 (es) 1993-11-30
US4639338A (en) 1987-01-27
NO165401B (no) 1990-10-29
CA1255694A (en) 1989-06-13
DK167282B1 (da) 1993-10-04
AR240832A1 (es) 1991-02-28
IE58077B1 (en) 1993-06-30
DD239597A5 (de) 1986-10-01
MX9203373A (es) 1992-09-01
IL75990A (en) 1989-07-31
FI79712B (fi) 1989-10-31
CY1570A (en) 1991-12-20
AU591066B2 (en) 1989-11-30
EP0177443B1 (de) 1989-10-18
ZA855892B (en) 1986-03-26
FI852986A0 (fi) 1985-08-02
DOP1990004769A (es) 1999-08-19
HK42591A (en) 1991-06-07
KR860001821A (ko) 1986-03-22
AR244696A1 (es) 1993-11-30
HU193124B (en) 1987-08-28
NO853087L (no) 1986-02-07
AR244698A1 (es) 1993-11-30
IE851931L (en) 1986-02-06
FI79712C (fi) 1990-02-12

Similar Documents

Publication Publication Date Title
DK355485A (da) Dinatrium-3-amino-l-hydroxy-propan-1,1-diphosphonat samt fremgangsmaade til fremstilling deraf
DK165248C (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
DK418985D0 (da) Indkapslede pyrethroider samt fremgangsmaade til fremstilling deraf oganvendelse som insecticid
DK273587D0 (da) 1,5-diaryl-3-substituerede pyrazoler samt fremgangsmaade til fremstilling deraf
DK307883A (da) Carbostyrilderivater samt fremgangsmaade til fremstilling deraf
DK54382A (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridiner samt fremgangsmaade til fremstilling deraf
DK93383A (da) Glycoproteiner samt fremgangsmaade til fremstilling heraf
DK161327C (da) Substituerede 2-piperazinopteridiner, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende forbindelserne
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK382785A (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK346889A (da) Heteropolysaccharid bm07, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DK431185A (da) Substituerede quinazolindioner samt fremgangsmaade til fremstilling deraf
DK115685A (da) Prespap samt fremgangsmaade til fremstilling deraf
DK113591A (da) 3-oe2-chlorethylaaquinazolin-2,4-dioner samt fremgangsmaade til fremstilling deraf
DK364483D0 (da) 14-aminosteroid-derivater samt fremgangsmade til fremstilling deraf
DK593985A (da) Olieadjuveret vaccine samt fremgangsmaade til fremstilling deraf
DK554885D0 (da) Krystallinsk zirconiumphosphat, samt fremgangsmaade til fremstilling af dette
DK504786A (da) Peptidforbindelser samt fremgangsmaade til fremstilling heraf
DK404587D0 (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK165182A (da) L-substitueret-4-phenyl-polyhydro-pyridiner og-pyrrolidiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK458082A (da) 2-isopropylamino-pyrimidin-n-oxid samt fremgangsmaade til fremstilling deraf
DK128684D0 (da) Kosttilskud samt fremgangsmaade til fremstilling heraf
DK993A (da) 3,4-trans-4-benzoylazetidin-2-oner samt fremgangsmaade til deres fremstilling

Legal Events

Date Code Title Description
PUP Patent expired